1.
Hennemann A, Agnès Collonge Rame M, Puzenat E, Ged C, Harbon S, Aubin F, et al. Efficacy of pembrolizumab in a patient with xeroderma pigmentosum variant and advanced cutaneous squamous-cell carcinoma. AO [Internet]. 2022 Sep. 2 [cited 2025 Feb. 16];61(9):1140-2. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/23828